Ciltacabtagene autoleucel (Carvykti)

Ciltacabtagene autoleucel (Carvykti) is a personalized treatment for multiple myeloma that uses your own immune cells to locate and destroy cancer cells. The process involves collecting your blood cells, modifying them in a specialized lab to recognize a specific protein on myeloma cells, and infusing them back into your body through a single IV. This space provides information on what to expect during the collection and infusion steps, potential side effects to monitor, and recovery guidelines. Connect with others to share practical experiences and learn how to manage daily life before, during, and after this treatment.